EQUITY RESEARCH — DEEP DIVE

Salesforce, Inc. (CRM)

Sector: / |
Published: 2026-05-26 |
Pages: 9

Executive Summary

Salesforce is, in our view at T&T Capital Management, the most consequential value-debate stock in U.S. large-cap software today. At $177.51 per share — down 32 percent year-to-date and the worst-performing Dow Jones component in 2026 — the stock trades at approximately 20 times consensus FY2027 non-GAAP EPS and roughly 4x consensus FY2027 revenue. The bull case rests on Agentforce — Salesforce’s AI-agent platform — which crossed $1.2 billion of annualized recurring revenue in Q1 FY27 with growth of 205 percent year-over-year. The bear case is that generative AI fundamentally threatens the seat-based SaaS pricing model that has been Salesforce’s moat for 25 years. The recent earnings print showed both sides of the debate.

What’s Inside The Full Report

  • 15-year financial summary table — revenue, net income, GAAP & adjusted EPS
  • Valuation framework — current multiples vs. 5-year historical range
  • Peer comparison table — multiples, margins, balance-sheet metrics
  • Base case, bull case, bear case price targets with explicit math
  • Competitive position and economic moat analysis
  • Management and capital allocation track record
  • Balance sheet review — leverage, credit ratings, distribution coverage
  • Insider activity — recent open-market buys / sells with interpretation
  • Strategic acquisitions and divestitures history
  • Sell-side consensus and where TTCM differs
  • Detailed risk factors specific to the name
  • Bull case and forward catalysts to watch
  • TTCM rating with explicit ADD / TRIM price triggers

Read The Full Report

The full 9-page report is available at no charge. Please complete the
brief form below and we’ll email the PDF to you within seconds.

T&T Capital Management LLC is a registered investment adviser. The research presented here reflects the firm’s opinions and is not personalized investment advice. Past performance is not indicative of future results. Form ADV available at adviserinfo.sec.gov.



Related research